NewsDialy
Heidi Overton is nominated to lead the Food and Drug Administration, a regulatory body tasked with approving medicines and ensuring product safety.
The short version is that she faces a critical test at her confirmation hearing, where she must address how the agency can keep pace with rapid medical innovation.
In plain terms, the FDA is under strain as new treatments arrive faster than the institutions designed to process them can handle.
The Confirmation Hearing Overton will appear before the Senate health committee on Thursday for her confirmation hearing.
Keep reading